Not Signed In -
Dexmethylphenidate |
Focalin |
Clinical Trial: Safety and Efficacy Study of Dexmethylphenidate in Children with ADHD
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD.
| Condition | Intervention | Phase |
|---|---|---|
| ADHD | Drug: Focalin XR | Phase III |
MedlinePlus related topics: Attention Deficit Disorder with Hyperactivity
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Crossover Assignment, Safety/Efficacy Study
Further Study Details:
Primary Outcomes: Reduction of symptoms in attention and deportment
Study start: June 2005
Eligibility
Ages Eligible for Study: 6 Years - 12 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- DSM-IV diagnosis of ADHD
- Males and females aged 6-12
Exclusion Criteria:
- Inability of understand or follow instructions
- Is pregnant
- Diagnosis of tic disorder
- History of seizure disorder
Location Information
Nevada
Center for Psychiatry & Behavioral Medicine, Las Vegas, Nevada, 89128, United States
Study chairs or principal investigators
Ann Childress, MD, Principal Investigator, Center for Psychiatry and Behavioral Medicine
More Information
Study ID Numbers: CRIT124EUS13
Last Updated: August 31, 2005
Record first received: August 30, 2005
ClinicalTrials.gov Identifier: NCT00141063
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-13
Last Updated: August 31, 2005
Record first received: August 30, 2005
ClinicalTrials.gov Identifier: NCT00141063
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- Dexmethylphenidate (Drug Digest)
- Focalin (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
